Journal article
Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months
FM Russell, A Balloch, PV Licciardi, JR Carapetis, L Tikoduadua, L Waqatakirewa, YB Cheung, EK Mulholland, MLK Tang
Vaccine | ELSEVIER SCI LTD | Published : 2011
Grants
Funding Acknowledgements
Funding was provided by NIAID and the National Health and Medical Research Council, Australia. Pneumovax (TM) was kindly donated by CSL Biotherapies, Australia. The co-administered Tritanrix (TM)-HepB (TM) and Hiberix (TM) vaccines were kindly donated by GlaxoSmithKline. Clinical trials number NCT00170612.